Apnimed, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States · Nasdaq: APMD
Apnimed, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2017. Its shares trade on Nasdaq under the ticker APMD. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2026.
Apnimed at a glance
What does Apnimed do?
Private fundraising reported to the SEC
15 Form D notices; the most recent reported $25 million sold (2026).
Frequently asked questions about Apnimed
Where is Apnimed headquartered?
Apnimed, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Apnimed do?
Apnimed, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Apnimed a public company?
Yes. Apnimed, Inc. trades on Nasdaq under the ticker APMD.
When was Apnimed founded?
The earliest incorporation on record for Apnimed, Inc. is in 2017, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Agios Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.